急诊床旁心脏超声对以胸痛就诊于急诊科的急性冠脉综合征的诊断准确性:一项单中心前瞻性研究
本研究为2022年在意大利Careggi大学医院急诊科开展的单中心前瞻性观察研究,纳入686例急性非创伤性胸痛成人患者,排除ST段抬高型心肌梗死和血流动力学不稳定者,由受训急诊医师在就诊时完成聚焦心脏超声(FoCUS)。以30天随访后盲法判定的NSTE-ACS为最终诊断,FoCUS检出节段性室壁运动异常者87例(12.7%),多因素logistic回归显示其为NSTE-ACS的独立预测因子。节段性室壁运动异常诊断NSTE-ACS的敏感性42.5%(95%CI 33.0-51.9)、特异性92.8%(95%CI 90.6-94.9)、阴性预测值89.8%(95%CI 87.4-92.2)、阳性预测值51.7%(95%CI 41.2-62.2),仅纳入1型NSTEMI的敏感性分析结果一致。作者认为,尽管高特异性提示FoCUS可能在NSTE-ACS的rule-in中发挥作用,但敏感性过低,不能仅凭FoCUS结果安全排除NSTE-ACS。
要点
- 在无ST段抬高的急诊胸痛患者中,FoCUS检出节段性室壁运动异常诊断NSTE-ACS的敏感性仅42.5%(95%CI 33.0-51.9),不能单独用于排除NSTE-ACS。
- FoCUS检出节段性室壁运动异常诊断NSTE-ACS的特异性为92.8%(95%CI 90.6-94.9),作者认为可能有助于rule-in NSTE-ACS。
- FoCUS检出节段性室壁运动异常的阴性预测值为89.8%(95%CI 87.4-92.2),阳性预测值为51.7%(95%CI 41.2-62.2)。
- 686例患者中106例(15.5%)最终判定为NSTE-ACS,其中67例为NSTEMI;87例(12.7%)FoCUS检出节段性室壁运动异常。
- 多因素logistic回归分析显示,FoCUS检出的节段性室壁运动异常是NSTE-ACS的独立预测因子。
适用人群与场景
- 2022年意大利Careggi大学医院急诊科,以急性非创伤性胸痛就诊的成人患者,无论既往是否存在节段性室壁运动异常均纳入。
- 排除ST段抬高型心肌梗死患者和血流动力学不稳定患者。
研究设计与关键结果
- 单中心前瞻性观察研究,纳入686例急诊胸痛患者,NSTE-ACS最终判定106例(15.5%),其中NSTEMI 67例。
- FoCUS由受训急诊医师在就诊时完成,检出节段性室壁运动异常87例(12.7%)。
- 多因素logistic回归分析显示节段性室壁运动异常是NSTE-ACS的独立预测因子。
- 节段性室壁运动异常诊断NSTE-ACS的敏感性42.5%(95%CI 33.0-51.9),特异性92.8%(95%CI 90.6-94.9),阴性预测值89.8%(95%CI 87.4-92.2),阳性预测值51.7%(95%CI 41.2-62.2)。
- 仅纳入1型NSTEMI的敏感性分析结果与主要分析一致。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,FoCUS检出节段性室壁运动异常的高特异性提示其可能在NSTE-ACS的rule-in中发挥作用。
- 作者认为,FoCUS敏感性过低,不能仅凭FoCUS结果安全排除NSTE-ACS。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND IMPORTANCE: The diagnostic accuracy of focused cardiac ultrasound (FoCUS) performed in patients presenting to the emergency department (ED) with chest pain is currently unknown.
OBJECTIVE: The objective of this study was to assess the diagnostic accuracy of regional wall motion abnormalities detected with FoCUS for non-ST-elevation acute coronary syndrome (NSTE-ACS) diagnosis.
DESIGN: A Single-center prospective observational study conducted in 2022 in the ED of the University Hospital Careggi, Italy.
SETTING AND PARTICIPANTS: Adult patients presenting to the ED with acute nontraumatic chest pain were enrolled, irrespective of the presence of previous regional wall motion abnormalities. Patients with ST-segment elevation myocardial infarctions and patients with hemodynamic instability were excluded. FoCUS was performed at presentation by a trained ED physician.
OUTCOME MEASURES AND ANALYSIS: The final diagnosis of NSTE-ACS vs. alternative diagnosis was adjudicated by an ED physician blinded to FoCUS results after a 30-day follow-up. To assess if regional wall motion abnormalities were an independent predictor of NSTE-ACS, a multivariable logistic regression model was built. Diagnostic performance measures were calculated. A sensitivity analysis considering only type-1 NSTEMIs (i.e. plaque rupture/thrombosis) was conducted.
MAIN RESULTS: Among 686 patients, NSTE-ACS was adjudicated in 106 (15.5%) patients, 67 of which were NSTEMIs. A total of 87 (12.7%) patients had regional wall motion abnormalities detected by FoCUS, which were an independent predictor of NSTE-ACS in the multivariable logistic regression analysis. Regional wall motion abnormalities had a sensitivity of 42.5% (33.0-51.9), a specificity of 92.8% (90.6-94.9), a negative predictive value of 89.8% (87.4-92.2), and a positive predictive value of 51.7% (41.2-62.2), for NSTE-ACS. Results were consistent in the sensitivity analysis.
CONCLUSIONS: In ED patients with chest pain and no ST elevation, the detection of regional wall motion abnormalities was a predictor of NSTE-ACS. Despite a high specificity, which indicated a possible role of FoCUS in the rule-in of NSTE-ACS, sensitivity was too low to allow a safe rule-out using FoCUS results alone.
参考来源
- Bima P, Agishev I, Fucile I, et al. Diagnostic accuracy of point-of-care cardiac ultrasound for acute coronary syndromes in patients presenting with chest pain to the emergency department: a single-center prospective study. Eur J Emerg Med. 2024. PMID: 38985842. doi:10.1097/MEJ.0000000000001161
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。